recommend that 25-hydroxyvitamin D levels should be assessed in all pHPT patients and vitamin D deficiency (VDD) should be cautiously corrected when detected (1). However it is unknown whether VDD affects the probability to meet surgical criteria currently proposed for A-pHPT.
Aim of this study was to evaluate whether VDD recognition affects the probability to meet surgical criteria in A-pHPT patients.
Introduction: Current guidelines for the management of asymptomatic primary hyperparathyroidism (A-pHPT) recommend that 25-hydroxyvitamin D levels should be assessed in all pHPT patients and vitamin D deficiency (VDD) should be cautiously corrected when detected. However it is unknown whether VDD affects the probability to meet surgical criteria currently proposed for A-pHPT. Aim of this study was to evaluate whether VDD recognition affects the probability to meet surgical criteria in A-pHPT patients.
Methods: 80 consecutive A-pHPT patients were studied (mean ± S.D. age: 66.5±8.9 years; male/female = 10/70 ; PTH: 179.8±134.7 ng/l, calcium: 10.8 ± 0.7 mg/dl; ionized calcium: 1.39± 0.10 mmol/l; 25OHD: 30.0 ± 21.3 ng/ml). VDD was defined as 25-hydroxyvitamin D < 20 ng/ml. The criteria for parathyroid surgery by the III International Workshop on the Management of ApHPT were considered, i.e.: Serum calcium >1 mg/dl the upper normal limit; Creatinine clearance <60 ml/min; T-score < -2.5 at any site.
Results : VDD was present in 32 patients (40%). A-pHPT patients with VDD showed higher PTH (240.8 ± 155.0 vs 139.1 ± 102.0 ng/l; p=0.0007), total (11.0 ± 0.7 vs 10.7 ± 0.66 mg/dl; p=0.04) and ionized calcium (1.42 ± 0.1 vs 1.37 ± 0.08 mmol/l; p=0.013) and lower forearm T score (-3.00 ± 1.5 vs -2.15 ± 1.4, p=0.019) compared with A-pHPT without VDD. No difference in fulfillment of any surgical criteria was present between A-pHPT patients with or without VDD (calcium criterion = 25% vs 14.6%, p =0.2586; eGFR criterion = 19.4% vs 21.7%, p=1.000; T-score criterion = 78.1 % vs 64.6 %, p=0.2226, respectively).
Conclusion: these findings show that VDD is not rarely detected in A-pHPT and affects biochemical and densitometric features; however, they indicate that recognition of VDD does not affect the probability to meet surgical criteria proposed by current guidelines in A-pHPT. Thus, the assessment of vitamin D status, as recommended, does not affect the therapeutical choice for surgery in A-pHPT.
VDD was present in 32 patients (40%).
A-pHPT patients with VDD showed higher PTH (240.8 ± 155.0 vs 139.1 ± 102.0 ng/l; p=0.0007), total (11.0 ± 0.7 vs 10.7 ± 0.66 mg/dl; p=0.04) and ionized calcium (1.42 ± 0.1 vs 1.37 ± 0.08 mmol/l; p=0.013) and lower forearm T score (-3.00 ± 1.5 vs -2.15 ± 1.4, p=0.019) compared with A-pHPT without VDD.
No difference in fulfillment of any surgical criteria was present between A-pHPT patients with or without VDD ( Table 2) .
VDD is frequently detected in A-pHPT and affects biochemical and densitometric features.
However, the recognition of VDD does not affect the probability to meet surgical criteria proposed by current guidelines in A-pHPT.
Thus, VDD recognition doesn't work as a predictor for surgery in A-pHPT patients .
For further informations : laura.gianotti@unito.it 80 consecutive A-pHPT patients (older than 50 yrs) were studied (mean ± S.D. age: 66.5±8.9 years; male/female = 10/70 ; PTH: 179.8±134.7 ng/l, calcium: 10.8 ± 0.7 mg/dl; ionized calcium: 1.39± 0.10 mmol/l; 25OHD: 30.0 ± 21.3 ng/ml).
VDD was defined as 25-hydroxyvitamin D < 20 ng/ml (2).
The criteria for parathyroid surgery by the III International Workshop on the Management of ApHPT were considered, i.e.: Serum calcium >1 mg/dl the upper normal limit; Creatinine clearance <60 ml/min; T-score < -2.5 at any site (1) . 
